Early evaluation of a screen-and-treat strategy using high-risk HPV testing for Uganda: Implications for screening coverage and treatment.

ABSTRACT:

Background

Uganda has a high burden of cervical cancer and its current coverage of screening based on visual inspection with acetic acid (VIA) is low. High-risk HPV (hrHPV) testing is recommended by the World Health Organization as part of the global elimination strategy for cervical cancer. In this context, country-specific health economic evaluations can inform national-level decisions regarding implementation. We evaluated the recommended hrHPV screen-and-treat strategy to determine the minimum required levels of coverage and treatment adherence, as well as the maximum price level per test, for the strategy to be cost-effective in Uganda.

Methods

We conducted a headroom analysis to estimate potential room for spending on implementing the hrHPV screen-and-treat strategy at

SUBMITTER: Sultanov M 

PROVIDER: S-EPMC11414519 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature